Lopixibat

• CAT Number: I007689
• CAS Number: 716313-53-0
• Molecular Formula: C40H56N3O4S+
• Molecular Weight: 674.96
• Purity: ≥95%
• Synonyms: Maralixibat; SHP-625; SHP625; SHP 625;1-(4-((4-((4R,5R)-3,3-dibutyl-7-(dimethylamino)-4-hydroxy-1,1-dioxido-2,3,4,5-tetrahydrobenzo[b]thiepin-5-yl)phenoxy)methyl)benzyl)-1,4-diazabicyclo[2.2.2]octan-1-ium
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term , or -20°C for long term.
• IUPAC Name: (4R,5R)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1$l^{6}
• InChI: InChI=1S/C40H56N3O4S/c1-5-7-19-40(20-8-6-2)30-48(45,46)37-18-15-34(41(3)4)27-36(37)38(39(40)44)33-13-16-35(17-14-33)47-29-32-11-9-31(10-12-32)28-43-24-21-42(22-25-43)23-26-43/h9-18,27,38-39,44H,5-8,19-26,28-30H2,1-4H3/q+1/t38-,39-/m1/s1
• InChIKey: STPKWKPURVSAJF-LJEWAXOPSA-N
• SMILES: CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC

Lopixibat(CAT: I007689) is a potent and selective inhibitor of ileal bile acid transporters (IBAT), also known as apical sodium-dependent bile acid transporters (ASBT). It plays a critical role in reducing bile acid reabsorption, making it a valuable tool for research into bile acid metabolism, cholesterol homeostasis, and related gastrointestinal disorders. Lopixibat is particularly useful for studying therapeutic strategies targeting conditions such as cholestatic liver diseases, irritable bowel syndrome (IBS), and hypercholesterolemia. With its high purity and specificity, Lopixibat supports advanced in vitro and in vivo experiments, contributing to drug discovery and development in metabolic and gastrointestinal research.